Please login to the form below

Not currently logged in
Email:
Password:

Richard Sorian joins Fleishman-Hillard

He will lead the Washington office’s growing healthcare division
FleishmanHillard RIchard Sorian

Fleishman-Hillard has added senior public affairs experience to its healthcare team with the appointment of Richard Sorian to lead the healthcare division of its office in Washington, DC.

The newly appointed senior vice president and partner joins from the District of Columbia's Health Benefit Exchange Authority, where he was director of communications, education and outreach.

Before joining the Authority, Sorian was assistant secretary for public affairs at the US Department of Health and Human Services (HHS), acting as chief adviser to the secretary on major communications strategies, responsible for steering the department's public affairs activities.

A 30-year healthcare communications veteran, Sorian also spent seven years as vice president for public policy and external relations at the National Committee for Quality Assurance, and served as senior advisor to HHS secretary Donna Shalala during the Clinton administration.

“Richard's vast experience will offer our clients a unique perspective on today's evolving communications challenges, and help our office reach new heights in this most competitive of sectors,” said Kris Balderston, general manager of Fleishman-Hillard's Washington office.

Sorian declared himself 'tremendously pleased' to be joining Fleishman-Hillard.

21st January 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....
Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...

Infographics